Gad Medical

What Gad Medical does

Gad Medical is a privately held, Israel-based pharmaceutical strategic partner founded in 2013. Rather than positioning itself as a conventional distributor, the company bills itself as the in-country headquarters for global pharmaceutical and MedTech manufacturers seeking entry and commercial success in Israel. It serves a narrow B2B customer segment — international pharma and MedTech sponsors — and operates a single-country footprint focused exclusively on the Israeli market.

The company delivers an integrated five-pillar service stack: Regulatory Affairs (MoH registration and lifecycle management), Market Access (pricing, reimbursement, and national health basket strategy), Medical Affairs (KOL engagement, medical education, scientific activities), Commercial Execution (go-to-market, positioning, field execution), and Distribution & Logistics (nationwide supply). Therapeutic focus spans cardiology, cardiovascular surgery, hematology, oncology, and orthopedics, with dedicated division heads. Revenue mechanics are not publicly disclosed; engagement is structured as bespoke B2B contracts with global pharma partners, marketed through direct outreach via a Head of Business Development and the company website.

Gad Medical reports having built over 30 global partnerships since founding and claims sustained double-digit annual growth. The firm is small (11-50 employees), founder/operator-led (CEO David Frances, COO Tzali Movshovitz, CFO Gilad Appelbaum), and concentrated in Aseret, Israel. No external funding, M&A activity, patents, certifications, or AI capabilities are disclosed.

Name

Gad Medical

Legal name

Gad Medical

Website

https://gadmedical.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Gad Medical is an Israel-based pharmaceutical strategic partner that serves as the in-country headquarters for global pharma and MedTech companies, providing regulatory affairs, market access, medical affairs, commercial execution, and nationwide distribution across five therapeutic areas.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Professional, Scientific, and Technical Services (54), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro industry

PRIMARYHLAIAAAB

Specialty Care Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAGALAM

KOL Engagement & Medical Education (Advisory Boards/CME Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

SECONDARYHLAGAOAG

Medical Affairs, Scientific Communications & HEOR FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• Pharmaceutical distribution
• Regulatory affairs services
• Market access consulting
• Medical affairs services
• Pharmaceutical logistics

Headquarters

HQ city

Rosh Ha'ayin

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Others

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Gad Medical is a fully integrated pharmaceutical strategic partner operating in Israel on behalf of global pharmaceutical and MedTech companies. The company delivers five end-to-end service capabilities — Regulatory Affairs, Market Access, Medical Affairs, Commercial Execution, and Distribution & Logistics — packaged as a single partnership offering that serves as the partner's HQ in Israel. Its therapeutic focus areas include Cardiology, Cardiovascular Surgery, Hematology, and Oncology, with Orthopedics also represented within the leadership team.

Product overview

Gad Medical operates as a fully integrated pharmaceutical strategic partner in Israel rather than a traditional product company. The company offers five interconnected service pillars: Regulatory Affairs, Market Access, Medical Affairs, Commercial Execution, and Distribution & Logistics. These services are delivered as an integrated platform to support global pharmaceutical and MedTech partners seeking market entry and commercial success in Israel. The company specializes in four therapeutic areas—Cardiology, Cardiovascular Surgery, Hematology/Oncology, and Orthopedics—serving as a strategic headquarters in Israel for international partners rather than acting as a mere distributor.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Services Registration strategy, Ministry of Health submissions, and lifecycle management for pharmaceutical products entering the Israeli market. Targeted at global pharmaceutical and MedTech companies requiring Israeli regulatory support.
• Market Access Services Pricing strategy, reimbursement negotiation, and national health basket positioning to ensure successful market entry in Israel. Targeted at global pharmaceutical companies seeking reimbursement and pricing outcomes in Israel.
• Medical Affairs Services Key Opinion Leader engagement, medical education programs, and scientific activities to support product adoption and clinical relationships. Targeted at global pharmaceutical partners requiring Israeli KOL and medical engagement.
• Commercial Execution Services Go-to-market strategy development, product positioning, and field execution to drive commercial success in the Israeli pharmaceutical market. Targeted at global pharmaceutical and MedTech partners launching products in Israel.
• Distribution & Logistics Services Reliable pharmaceutical supply chain management, logistics operations, and nationwide distribution throughout Israel. Targeted at global pharmaceutical and MedTech companies requiring physical product distribution across Israel.
• Cardiology Solutions Introduction and adoption support for advanced cardiology solutions through established relationships with leading physicians and hospital teams in Israel. Therapeutic focus area delivered through the company's integrated partnership model.
• Cardiovascular Surgery Solutions Bringing advanced cardiovascular surgical solutions to the Israeli market through partnerships with hospital teams involved in complex cardiac procedures. Therapeutic focus area delivered through the company's integrated partnership model.
• Hematology/Hemato-Oncology Solutions Supporting innovative therapies for complex blood-related cancers and chronic hematologic conditions, enabling successful market entry and long-term adoption in Israel. Therapeutic focus area delivered through the company's integrated partnership model.
• Oncology Solutions Supporting adoption of innovative cancer care solutions through local experience and physician relationships for patients with complex oncological needs. Therapeutic focus area delivered through the company's integrated partnership model.
• Orthopedics Solutions Specialized orthopedic medical solutions distributed and supported in the Israeli market through local expertise and clinical partnerships. Therapeutic focus area delivered through the company's integrated partnership model.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• IQVIA: Global clinical, commercial, and market access services giant with deep pharma commercialization offerings. Comparable as a broader, scaled version of Gad Medical's regulatory, market access, and commercial execution capabilities.
• Syneos Health: End-to-end biopharmaceutical solutions provider spanning clinical development and commercial services. Comparable to Gad Medical in offering integrated commercialization services for pharma, but at global scale.
• Teva Pharmaceutical Industries: Israel's largest pharmaceutical company with global operations spanning generics, specialty, and biopharmaceuticals. Overlaps Gad Medical's space as the dominant domestic pharma incumbent with broad regulatory, commercial, and distribution capabilities.
• Inizio: Global pharma commercialization platform encompassing Ashfield, Evoke, and acquirexi. Overlaps with Gad Medical's KOL engagement, medical affairs, and field execution services at a much larger, multi-geography scale.

Others

• ZS Associates: Global management consulting and technology firm focused on healthcare and life sciences commercial strategy, market access, and field force design. Adjacent competitor for the strategic advisory layer of Gad Medical's commercial execution offering.
• McKinsey & Company: Global strategy consulting firm with a substantial pharma and life sciences practice advising on market entry, market access, and commercial transformation. Adjacent to the strategic-HQ positioning Gad Medical uses to win global pharma mandates.

Regional players

• Dexcel Pharma: Israel-headquartered specialty pharmaceutical company with international distribution. Comparable as another Israeli-rooted pharma commercial player with overlapping specialty therapeutic orientation.

Direct peers

• Rafa Laboratories: Israeli pharmaceutical manufacturer and distributor with proprietary products and partner distribution activities. Comparable in serving the Israeli pharmaceutical value chain via combined manufacturing/representation plus distribution.
• Neopharm Group: Long-established Israeli pharmaceutical and medical device distribution and commercialization group operating across multiple therapeutic categories. Direct overlap with Gad Medical's pharma distribution and market entry role in Israel.
• Medison Pharma: Israel-based pharma commercialization partner that helps international biotech and pharma companies access the Israeli market via distribution, market access, and regulatory services. Closest functional analogue to Gad Medical's 'HQ in Israel' model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gad Medical